QIC invests in Australian biotech start-up

A $2.2 million pre-seed round led by early-stage investor Jelix Ventures alongside QIC and Angelloop will support Gelomics' continued market expansion.

Upgrade your subscription to access this article

Subscribe to gain unlimited access to news, research and analysis of ESG factors for ASX listed companies and investors.
Become a premium subscriber today.
Already A Subscriber?

Read more: GelomicsAngelloopJelix VenturesChristoph MeinertQIC VenturesPatrick ChristiansenQueensland Investment CorporationEnterprise Acceleration Fund